Paul Edward Kelly, Director at RELMADA THERAPEUTICS, INC. (RLMD), sold 5,638 shares at $35.04 ($199K) on 2021-02-08, disclosed to the SEC on 2021-02-10.
Open-market sale of $199k RLMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.04 | 1,500 | $53K | 26.5% |
| 2 | $35.29 | 2,069 | $73K | 36.8% |
| 3 | $35.29 | 2,069 | $73K | 36.8% |
| Total | $35.22 avg | 5,638 | $199K | 100% |
| Filing → |
| RLMD | BUY | 2024-09-11 | $65K | — | Filing → |
| RLMD | SELL | 2022-04-05 | $300K | — | Filing → |
| RLMD | SELL | 2021-03-11 | $357K | — | Filing → |